跳至主要内容
临床试验/EUCTR2006-003194-27-BE
EUCTR2006-003194-27-BE进行中(未招募)1 期

mirtazapine versus placebo in functional dyspepsia: a randomized, double-blind, placebo-controlled trial - mirtazapine versus placebo in functional dyspepsia

niversity Hospitals KU Leuven0 个研究点目标入组 60 人开始时间: 2006年8月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • functional dyspepsia diagnosed according to international consensus criteria (Rome II criteria)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. organic gastro-intestinal disorders (for example oesophagitis, peptic ulcer, gastritis)
  • 2. current psychiatric disorders (mood & anxiety disorders, eating disorders, psychosis)
  • 3. intake of prokinetic and/or spasmolytic drugs (PPI allowed)
  • 4. intake of antidepressants (SSRI, TCA) and/or neuroleptics during the past two months
  • 5. intake of analgetics (paracetamol allowed)
  • 6. history of major abdominal surgery
  • 7. pregnancy or lactation
  • 8. recent exposure to significant radiation

研究者

发起方
niversity Hospitals KU Leuven

相似试验